Keyan Wang

819 total citations
51 papers, 544 citations indexed

About

Keyan Wang is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Keyan Wang has authored 51 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Immunology. Recurrent topics in Keyan Wang's work include Monoclonal and Polyclonal Antibodies Research (18 papers), Glycosylation and Glycoproteins Research (9 papers) and Immunotherapy and Immune Responses (7 papers). Keyan Wang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (18 papers), Glycosylation and Glycoproteins Research (9 papers) and Immunotherapy and Immune Responses (7 papers). Keyan Wang collaborates with scholars based in China, United States and Germany. Keyan Wang's co-authors include Zhiqin Bu, Yingpu Sun, Wei Dai, Xiaolong Wang, Liping Dai, Jie Chen, Yiping Li, Jianxiang Shi, Peng Wang and Hua Ye and has published in prestigious journals such as PLoS ONE, Scientific Reports and Coordination Chemistry Reviews.

In The Last Decade

Keyan Wang

44 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keyan Wang China 12 183 174 146 140 104 51 544
Chun Gao China 11 78 0.4× 73 0.4× 59 0.4× 45 0.3× 24 0.2× 26 437
F.J. Rodríguez‐Escudero Spain 11 103 0.6× 165 0.9× 195 1.3× 30 0.2× 11 0.1× 47 478
Cundong Liu China 14 311 1.7× 111 0.6× 187 1.3× 76 0.5× 34 0.3× 48 627
T Kolben Germany 12 98 0.5× 31 0.2× 23 0.2× 96 0.7× 18 0.2× 36 375
Fufan Zhu China 13 209 1.1× 103 0.6× 49 0.3× 99 0.7× 4 0.0× 22 578
Αnastasia Bothou Greece 7 112 0.6× 41 0.2× 40 0.3× 27 0.2× 19 0.2× 53 368
Han Witjes United States 14 105 0.6× 400 2.3× 402 2.8× 49 0.3× 11 0.1× 35 653
Jacek Sieńko Poland 11 64 0.3× 67 0.4× 45 0.3× 80 0.6× 8 0.1× 33 374
Jingky Lozano-Kühne United Kingdom 10 175 1.0× 44 0.3× 13 0.1× 130 0.9× 15 0.1× 22 437
Bingying Xie China 13 124 0.7× 16 0.1× 128 0.9× 61 0.4× 9 0.1× 17 459

Countries citing papers authored by Keyan Wang

Since Specialization
Citations

This map shows the geographic impact of Keyan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyan Wang more than expected).

Fields of papers citing papers by Keyan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyan Wang. The network helps show where Keyan Wang may publish in the future.

Co-authorship network of co-authors of Keyan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Keyan Wang. A scholar is included among the top collaborators of Keyan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyan Wang. Keyan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Li, Yuqi Liu, Qian Yang, et al.. (2025). Serum autoantibody signatures enable non-invasive early detection of pancreatic cancer. Pancreatology. 26(1). 114–122.
2.
Liu, Xiangning, Rongxin Zhu, Ying Sun, et al.. (2025). Phenotypic screening uncovered anti-myocardial fibrosis candidates using a novel 3D myocardial tissue under hypoxia. Acta Pharmaceutica Sinica B. 15(6). 3008–3024. 1 indexed citations
4.
Wang, Keyan, Qing Li, Pengfei Ren, et al.. (2025). A nomogram based on autoantibodies for noninvasive detection of AFP-negative hepatocellular carcinoma: a multicenter study. British Journal of Cancer. 133(12). 1896–1906.
5.
Qiu, Zhongmin, Yifan Cheng, Tao Li, et al.. (2025). Screening colorectal cancer associated autoantigens through multi-omics analysis and diagnostic performance evaluation of corresponding autoantibodies. BMC Cancer. 25(1). 713–713. 3 indexed citations
6.
Wang, Keyan, Rongxin Zhu, Junjun Li, et al.. (2025). The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation study. Journal of Traditional Chinese Medical Sciences. 12(3). 336–347.
7.
Li, Zongjun, Jie Song, Keyan Wang, et al.. (2025). Mito-Nanozyme: Mitochondria-Targeted Nanozyme for Cancer Therapy. Coordination Chemistry Reviews. 542. 216899–216899. 5 indexed citations
9.
Wang, Keyan, et al.. (2025). The association between Vitamin D deficiency and clinical pregnancy rate in IVF patients with different age. Frontiers in Endocrinology. 15. 1485238–1485238. 2 indexed citations
10.
Chen, Jiajun, et al.. (2024). Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cancer Prevention Research. 17(5). 227–235. 1 indexed citations
11.
Cheng, Yifan, Qing Li, Guiying Sun, et al.. (2024). Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer. Scientific Reports. 14(1). 9757–9757.
12.
Li, Qing, Haiyan Liu, Han Wang, et al.. (2024). Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma. PeerJ. 12. e17494–e17494. 1 indexed citations
13.
Sun, Guiying, Huili Chen, Tiandong Li, et al.. (2023). Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma. International Immunopharmacology. 125(Pt A). 111041–111041. 1 indexed citations
14.
Wang, Keyan, Xiaoqian Sun, Ying Sun, et al.. (2023). Transcriptional regulation of macrophages in heart failure. Frontiers in Cardiovascular Medicine. 10. 1148041–1148041. 4 indexed citations
15.
Yang, Qian, Hua Ye, Guiying Sun, et al.. (2023). Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma. Molecular Oncology. 17(5). 887–900. 9 indexed citations
17.
Wang, Keyan, et al.. (2021). Role of epigenetic regulation in myocardial ischemia/reperfusion injury. Pharmacological Research. 170. 105743–105743. 74 indexed citations
18.
Tang, Wenyi, Keyan Wang, Qing Chang, Xin Huang, & Gezhi Xu. (2021). A simple new technique for the induction of residual posterior vitreous cortex removal and membrane peeling. International Journal of Ophthalmology. 14(4). 622–625. 1 indexed citations
19.
Bu, Zhiqin, et al.. (2016). Risk factors for ectopic pregnancy in assisted reproductive technology: a 6-year, single-center study. Fertility and Sterility. 106(1). 90–94. 52 indexed citations
20.
Hu, Linli, Zhiqin Bu, Keyan Wang, & Yingpu Sun. (2014). Recombinant luteinizing hormone priming in early follicular phase for women undergoing in vitro fertilization: Systematic review and meta-analysis. Journal of International Medical Research. 42(2). 261–269. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026